Brain transcriptomic profiling in idiopathic and LRRK2-associated Parkinson's disease

Brain Research

Volumn 1466, Issue , 2012, Pages 152-157

  Botta Orfila, Teresa ^a   Sànchez Pla, Alex ^b,c   Fernández, Manel ^a   Carmona, Francesc ^b   Ezquerra, Mario ^a,d   Tolosa, Eduard ^a,d  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Locus coeruleus; LRRK2; Microarray; Parkinson's disease

Indexed keywords

HLA ANTIGEN CLASS 2; LEUCINE RICH REPEAT KINASE 2;

ARTICLE; CHROMOSOME; CHROMOSOME 6P21.3; DISEASE ASSOCIATION; GENE EXPRESSION; GENE MUTATION; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC PARKINSON DISEASE; MICROARRAY ANALYSIS; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION; TRANSCRIPTOMICS;

BRAIN; DATABASES, GENETIC; GENE EXPRESSION PROFILING; HUMANS; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTOME;

EID: 84862976137     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.05.036     Document Type: Article

References (28)

1. J. Alegre-Abarrategui, O. Ansorge, M. Esiri, and R. Wade-Martins LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's disease Neuropathol. Appl. Neurobiol. 34 3 2008 272 283 (Pubitemid 351590862)
2. F. Al-Shahrour, R. Diaz-Uriarte, and J. Dopazo (FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes Bioinformatics 20 2004 578 580 (Pubitemid 38344339)
3. F. Al-Shahrour, L. Arbiza, H. Dopazo, J. Huerta-Cepas, P. Minguez, D. Montaner, and J. Dopazo (From genes to functional classes in the study of biological systems BMC Bioinforma 8 2007 114
4. S.J. Baloyannis, V. Costa, and I.S. Baloyannis Morphological alterations of the synapses in the locus coeruleus in Parkinson's disease J. Neurol. Sci. 248 1-2 2006 35 41 (Pubitemid 44647280)
5. T. Botta-Orfila, E. Tolosa, E. Gelpi, A. Sanchez-Pla, M.J. Marti, F. Valldeoriola, M. Fernandez, F. Carmona, and M. Ezquerra Microarray expression analysis in idiopathic and LRRK2-associated Parkinson's disease Neurobiol. Dis. 45 1 2012 462 468
6. R. Cash, T. Dennis, R. L'Heureux, R. Raisman, F. Javoy-Agid, and B. Scatton Parkinson's disease and dementia: norepinephrine and dopamine in locus ceruleus Neurology 37 1987 42 46 (Pubitemid 17230106)
7. A.L. DeFranco, R. Locksley, and M. Robertson Immunity: the immune response in infections and inflammatory disease 2007 New Science Press Ltd. London, United Kingdom
8. A. Di Fonzo, C.F. Rohé, J. Ferreira, H.F. Chien, L. Vacca, F. Stocchi, L. Guedes, E. Fabrizio, M. Manfredi, N. Vanacore, S. Goldwurm, G. Breedveld, C. Sampaio, G. Meco, E. Barbosa, B.A. Oostra, V. Bonifati Italian Parkinson Genetics Network A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease Lancet 365 9457 2005 412 415 (Pubitemid 40179228)
9. R. Edgar, M. Domrachev, and A.E. Lash Gene Expression Omnibus: NCBI gene expression and hybridization array data repository Nucleic Acids Res. 30 1 2002 207 210 (Pubitemid 34679544)
10. D. Galter, M. Westerlund, A. Carmine, E. Lindqvist, O. Sydow, and L. Olson (LRRK2 expression linked to dopamine-innervated areas Ann. Neurol. 59 2006 714 719
11. H.M. Gao, F. Zhang, H. Zhou, W. Kam, B. Wilson, and J.S. Hong Neuroinflammation and alpha-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease Environ. Health Perspect. 119 2011 807 814
12. W.P. Gilks, P.M. Abou-Sleiman, S. Gandhi, S. Jain, A. Singleton, A.J. Lees, K. Shaw, K.P. Bhatia, V. Bonifati, N.P. Quinn, J. Lynch, D.G. Healy, J.L. Holton, T. Revesz, and N.W. Wood A common LRRK2 mutation in idiopathic Parkinson's disease Lancet 365 9457 2005 415 416 (Pubitemid 40179229)
13. T.H. Hamza, C.P. Zabetian, A. Tenesa, A. Laederach, J. Montimurro, D. Yearout, D.M. Kay, K.F. Doheny, J. Paschall, E. Pugh, V.I. Kusel, R. Collura, J. Roberts, A. Griffith, A. Samii, W.K. Scott, J. Nutt, S.A. Factor, and H. Payami (Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease Nat. Genet. 42 2010 781 785
14. S. Higashi, S. Biskup, A.B. West, D. Trinkaus, V.L. Dawson, R.L. Faull, H.J. Waldvogel, H. Arai, T.M. Dawson, D.J. Moore, and P.C. Emson (Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain Brain Res. 1155 2007 208 219 (Pubitemid 46900930)
15. O. Hornykiewicz, and S.J. Kish (Biochemical pathophysiology of Parkinson's disease Adv. Neurol. 45 1987 19 34
16. R.A. Irizarry, B. Hobbs, F. Collin, Y.D. Beazer-Barclay, K.J. Antonellis, U. Scherf, and T.P. Speed (Exploration, normalization, and summaries of high density oligonucleotide array probe level data Biostatistics 4 2003 249 264
17. K. Kapur, Y. Xing, and Z. Ouyang Wong WH (exon arrays provide accurate assessments of gene expression Genome Biol. 8 2007 R82
18. X. Liu, R. Cheng, M. Verbitsky, S. Kisselev, A. Browne, H. Mejia-Sanatana, E.D. Louis, L.J. Cote, H. Andrews, C. Waters, B. Ford, S. Frucht, S. Fahn, K. Marder, L.N. Clark, and J.H. Lee Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population BMC Med. Genet. 12 2011 104
19. D.M. Mann The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system Mech. Ageing Dev. 23 1983 73 94 (Pubitemid 14240536)
20. M.R. Marien, F.C. Colpaert, and A.C. Rosenquist Noradrenergic mechanisms in neurodegenerative diseases: a theory Brain Res. Brain Res. Rev. 45 2004 38 78 (Pubitemid 38520015)
21. I. Medina, J. Carbonell, L. Pulido, S.C. Madeira, S. Goetz, A. Conesa, J. Tarraga, A. Pascual-Montano, R. Nogales-Cadenas, J. Santoyo, F. Garcia, M. Marba, D. Montaner, and J. Dopazo Babelomics: an integrative platform for the analysis of transcriptomics, proteomics and genomic data with advanced functional profiling Nucleic Acids Res. 38 2010 W210 W213
22. J. Miklossy, T. Arai, J.P. Guo, A. Klegeris, S. Yu, E.G. McGeer, and P.L. McGeer LRRK2 expression in normal and pathologic human brain and in human cell lines J. Neuropathol. Exp. Neurol. 65 2006 953 963 (Pubitemid 44521796)
23. W.C. Nichols, N. Pankratz, D. Hernandez, C. Paisán-Ruíz, S. Jain, C.A. Halter, V.E. Michaels, T. Reed, A. Rudolph, C.W. Shults, A. Singleton, T. Foroud Parkinson Study Group-PROGENI investigators Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease Lancet 365 9457 2005 410 412 (Pubitemid 40179227)
24. L. Qian, P.M. Flood, and J.S. Hong (Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy J. Neural. Transm. 117 2010 971 979
25. G.K. Smyth Linear models and empirical bayes methods for assessing differential expression in microarray experiments Stat. Appl. Genet. Mol. Biol. 3 2004 (Article3)
26. M.G. Tansey, and M.S. Goldberg (Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention Neurobiol. Dis. 37 2010 510 518
27. G. Turturici, G. Sconzo, and F. Geraci (Hsp70 and its molecular role in nervous system diseases Biochem. Res. Int. 2011 2011 618127
28. P.S. Whitton Neuroinflammation and the prospects for anti-inflammatory treatment of Parkinson's disease Curr. Opin. Investig. Drugs 11 2010 788 794